Sale!

Revolade 25mg Tablets – Eltrombopag Olamine

Original price was: ₨ 75,600.Current price is: ₨ 75,000.

Revolade is a brand name for the medication containing the active ingredient Eltrombopag Olamine. Eltrombopag belongs to a class of drugs called thrombopoietin receptor agonists, which work by stimulating the production of platelets in the body.

Category:

Description

Maintaining adequate platelet levels is crucial for preventing bleeding complications.

For individuals with conditions associated with low platelet counts, medications like Revolade 25mg Tablets – Eltrombopag Olamine can offer a valuable solution.

In this article, we will explore the benefits, usage, and precautions associated with Revolade, shedding light on its ability to stimulate platelet production and enhance overall health.

Understanding Revolade 25mg Tablets – Eltrombopag Olamine:

Revolade is an oral medication that contains Eltrombopag Olamine as its active ingredient.

It belongs to a class of drugs known as thrombi protein receptor agonists, which work by stimulating the production of platelets in the bone marrow.

By increasing platelet levels, Revolade helps reduce the risk of bleeding complications and improves overall well-being.

Benefits of Revolade 25mg Tablets – Eltrombopag Olamine:

Platelet Stimulation:

Revolade effectively stimulates platelet production, which is beneficial for individuals with conditions like chronic immune thrombocytopenia (ITP) and severe aplastic anemia (SAA).

By boosting platelet counts, it helps minimize the risk of bleeding episodes and enhances quality of life.

Symptom Relief:

Low platelet counts can cause symptoms such as easy bruising, prolonged bleeding, and fatigue.

Revolade helps alleviate these symptoms by raising platelet levels, allowing individuals to engage in their daily activities without the fear of excessive bleeding or injury.

Personalized Treatment:

Revolade can be used as a standalone therapy or in combination with other treatments, depending on the specific condition and individual needs.

It provides flexibility in managing platelet disorders and allows for personalized treatment approaches.

Usage and Dosage:

Revolade 25mg Tablets – Eltrombopag Olamine are taken orally, usually once daily, as directed by a healthcare professional.

The dosage may vary based on the individual’s condition and response to treatment.

It is essential to follow the prescribed dosage and consult with a healthcare provider for personalized guidance.

Precautions and Side Effects:

While Revolade is generally well-tolerated, it is important to be aware of potential side effects and take necessary precautions:

Liver Monitoring:

Regular monitoring of liver function is necessary while using Revolade, as it can affect liver enzymes.

Individuals with a history of liver disease or those taking other medications that impact liver function should inform their healthcare provider.

Blood Clotting:

Revolade may increase the risk of blood clot formation, particularly in individuals with certain medical conditions.

Close monitoring and adjustment of the dosage may be necessary to minimize this risk.

Pregnancy and Breastfeeding:

Revolade should be used with caution during pregnancy or while breastfeeding.

It is crucial to discuss the potential risks and benefits with a healthcare provider.

Conclusion:

Revolade 25mg Tablets – Eltrombopag Olamine offer an effective solution for individuals with low platelet counts.

By stimulating platelet production, Revolade improves overall health and reduces the risk of bleeding complications.

However, it is essential to use Revolade under medical supervision, follow the prescribed dosage, and monitor for potential side effects.

Consult with a healthcare provider for personalized advice on managing platelet disorders and determining the most suitable treatment plan for your specific needs.

Buy:Revolade (Eltrombopag Olamine) 50mg Tablets

Reviews

There are no reviews yet.

Be the first to review “Revolade 25mg Tablets – Eltrombopag Olamine”

Your email address will not be published. Required fields are marked *